Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $47.23 USD
Change Today +0.14 / 0.30%
Volume 422.4K
MDSO On Other Exchanges
As of 5:20 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

medidata solutions inc (MDSO) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/21/14 - $52.72
52 Week Low
05/7/14 - $32.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

medidata solutions inc (MDSO) Related Bloomberg News

View More Bloomberg News

medidata solutions inc (MDSO) Related Businessweek News

No Related Businessweek News Found

medidata solutions inc (MDSO) Details

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company offers applications and data analytics for clinical development. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a clinical business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud application for electronic patient-reported outcome; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of cloud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. Medidata Solutions, Inc. markets and sells its cloud-based solutions through direct sales force, as well as through relationships with CROs and other strategic partners. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

1,077 Employees
Last Reported Date: 03/2/15
Founded in 1999

medidata solutions inc (MDSO) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $497.9K
Co-Founder, President, Director and President...
Total Annual Compensation: $497.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $339.2K
Chief Operating Officer
Total Annual Compensation: $112.5K
Chief Commercial Officer
Total Annual Compensation: $325.0K
Compensation as of Fiscal Year 2014.

medidata solutions inc (MDSO) Key Developments

Medidata Expands Partnership with Peking University Clinical Research Institute to Increase Access to Cloud-Based Technology for Clinical Trials Across China

Medidata announced the expansion of its partnership with Peking University Clinical Research Institute. Leveraging the research institute’s extensive clinical development network, expertise and resources, the partnership will accelerate the adoption of the Medidata Clinical Cloud® platform across China and, in doing so, optimize local drug development programs by bringing operational efficiencies and greater speed to clinical trials. Combining cloud-based solutions with deep expertise in clinical development, Medidata and PUCRI have collaborated for several years to introduce innovative technology into clinical research in China. Together, they are helping life sciences companies improve operational efficiencies and increase productivity across China’s clinical research programs. In expanding their partnership, Medidata and PUCRI will provide life sciences companies in China with increased accessibility to technology that streamlines clinical trials and, ultimately, helps to accelerate the delivery of novel therapies to patients.

Accenture Expands Accelerated R&D Services by Selecting Medidata Solutions' Cloud-Based Electronic Data Capture and Management System

Accenture has expanded its Accelerated R&D Services by selecting Medidata Solutions' cloud-based electronic data capture and management system Medidata Rave® to complement its cloud-based solution. Accenture's Accelerated R&D Services help clients streamline clinical trial set-up time and improve data efficiency, productivity, and transparency. Medidata's technology platform provides a set of solutions, benchmarking data and industry analytics to improve operational efficiencies, resource savings and decision-making processes. As part of Accenture Accelerated R&D services, Accenture is also enhancing its Life Sciences Cloud for R&D solution by integrating it with the Medidata Clinical Cloud®, a vertical software-as-a-service (SaaS) platform designed to transform the clinical research process for life sciences companies and the patients who depend on them by increasing speed to market, lowering risk, and improving therapeutic value. The integrated offering will enable life sciences companies to configure their clinical data warehouses based upon trial design in Rave. Together, Accenture and Medidata are creating submission-compliant deliverables to help clients address regulatory needs early.

Cancer Research UK and Medidata Partner to Streamline Data Collection and Management for Cancer Clinical Trials

Medidata and Cancer Research UK announced that the Medidata Clinical Cloud® has been selected to support the charity’s ground-breaking drug discovery research. In collaboration with academic and industry partners, Cancer Research UK’s Centre for Drug Development (CDD) translates exciting new discoveries made in the lab into cutting-edge new cancer treatments for patients. To further this work, the CDD is leveraging Medidata’s cloud-based technology for electronic data capture and management (Medidata Rave®) to conduct faster, safer clinical trials at institutes, universities and hospitals across the UK.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDSO:US $47.23 USD +0.14

MDSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DATATRAK International Inc $5.65 USD -0.25
Enzo Biochem Inc $3.03 USD +0.18
Luminex Corp $16.35 USD -0.12
OmniComm Systems Inc $0.26 USD +0.026
Oracle Corp $43.42 USD +0.10
View Industry Companies

Industry Analysis


Industry Average

Valuation MDSO Industry Range
Price/Earnings 100.0x
Price/Sales 7.4x
Price/Book 9.4x
Price/Cash Flow 426.5x
TEV/Sales 6.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIDATA SOLUTIONS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at